Padagis LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Padagis LLC - overview
Established
2004
Location
Allegan, MI, US
Primary Industry
Pharmaceuticals
About
Based in the US, and founded in 2004 as the Rx division of Perrigo, Padagis LLC operates as a provider of generic prescription pharmaceutical products for its customers. As of 2021, the firm has more than 1,300 employees and has 6 locations in Israel and the US. Altaris Capital Partners acquired the company from Perrigo Company Plc for approximately USD 1. 55 billion including USD 1.
5 billion in cash in July 2021. The company manufactures and offers a category of generic drugs, over-the-counter, and dermatological products such as prescription creams, gels, foams, sprays, patches, nasal, ointments, suspensions, and suppositories for patients.
Current Investors
Altaris
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.padagis.com
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Padagis LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Padagis LLC | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.